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Abstract
Introduction: Sodium acetate has been shown to cause hemodynamic instability when used as a hemodialysis
buffer. The pattern of hemodynamic response to injury will be evaluated between those who received sodium
acetate and those who did not.
The primary purpose of the study is to analyze the effect of sodium acetate on hemodynamic parameters.
Secondarily we looked at the effects on prevention and treatment of hyperchloremic metabolic acidosis.
Methods: The study arm was comprised of patients who had received sodium acetate infusions in place of normal
saline between March 2005 and December 2009. A control arm was created based on matching three pre-
treatment variables: injury severity score (ISS), pH (+/- 0.03) and base deficit (+/- 3). A retrospective chart review
was performed for patients in both arms. Blood pressure, arterial blood gas data and chemistry values were
recorded for the time points of -6, -1, 0, 1, 6, 12, 24, 48, and 72 hours from start of sodium acetate infusion.
Patients were excluded based on the following criteria: patients who were given sodium bicarbonate within 48
hours of starting sodium acetate, those given sodium acetate as a bolus, non-trauma patients, burn patients,
patients who expired within 24 hours of arrival to the ICU, patients diagnosed with rhabdomyolysis and patients
whose medical record could not be obtained.
Results: A total of 78 patients were included in the study, 39 in the study arm and 39 in the control arm. There
were no statistically significant drops in blood pressure within either group. The median pH between the two
groups at the start of infusion was equal. Both groups trended towards normal pH with the study arm improving
faster than the control arm. The median serum bicarbonate at start of sodium acetate infusion was 19 mmol/L and
20 mmol/L at time zero for the study and control arms respectively with both trending upward during the study
period. Chloride trended up initially in both groups but the study arm began to correct sooner at 24 hours
compared to 48 hours for the control arm.
Conclusion: We analyzed the use of sodium acetate as an alternative to normal saline or lactated ringers during
resuscitation of critically ill trauma patients at a single center. Our data shows that the hemodynamic profile
remained favorable, without evidence of instability at any point during the study period. Normalization of
hyperchloremia and metabolic acidosis occurred faster in the patients who received sodium acetate.
Introduction
One of the most common acid-base disorders seen in
trauma patients is metabolic acidosis due to hyperchlore-
mia during resuscitation. In order to prevent and minimize
hyperchloremic metabolic acidosis, our institution began to
use sodium acetate during resuscitation of trauma patients.
As an alternative to normal saline (154 mEq/L chloride)
and lactated ringers (109 mEq/L chloride), sodium acetate
provides a regimen free of chloride. A source of fixed base,
sodium acetate also helps to correct acidosis in patients
already acidotic. Acetate is metabolized in muscle to
acetyl-CoA which is later used in the TCA cycle where
bicarbonate is produced. The use of sodium acetate during
resuscitation of trauma patients is presented.
Historically, sodium acetate has been used as a fluid
bath for hemodialysis. It became a viable alternative to
bicarbonate in the 1960’s because of the incompatibility
of bicarbonate with solutions containing calcium and
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sodium acetate may cause cardiovascular instability in
hemodialysis patients. Clinical administration of acetate
as part of the hemodialysis treatment is known to be
associated with vasodilation and impaired cardiac con-
tractile response [2,3]. Studies on acetate-based dialy-
sates have shown undesirable metabolic side effects such
as hypotensive episodes [2,3].
Today, the use of acetate as a hemodialysis buffer is lim-
ited. There are few published reports of the use of sodium
acetate in non-dialysis patients. In 1978, Kirkendol et al
reported that a slow infusion of sodium acetate in dogs
did not show a reduction in blood pressure [1]. And as
early as 1969, Watten et al showed that sodium acetate
solution approached bicarbonate in its ability to restore
blood pH and plasma bicarbonate in patients suffering
from cholera with metabolic acidosis [4,5]. In 1985, Ekblad
et al reported that the continuous infusion of sodium acet-
ate is suitable for the slow correction of metabolic acidosis
in premature infants [6]. In spite of the fact that it can be
used as an effective buffer in metabolic acidosis, its use
has not become widespread [4]. The use of sodium acetate
during resuscitation would require a significantly lower
acetate load then that previously used for hemodialysis.
The hemodynamic effects of sodium acetate in non-
hemodialysis patients are unknown. As of this writing,
there are no studies evaluating the hemodynamic effects of
sodium acetate infusion in trauma patients. Since 2005,
our institution has been using sodium acetate in critically
ill trauma patients in an effort to prevent and treat hyper-
chloremic metabolic acidosis. The pattern of hemody-
namic response to injury will be evaluated between those
who received sodium acetate and those who did not. The
primary purpose of the study is to analyze the effect of
sodium acetate on hemodynamic parameters. Secondarily
we looked at the effects on prevention and treatment of
hyperchloremic metabolic acidosis.
Methods
Patients who received sodium acetate while in the Surgi-
cal Intensive Care Unit (SICU) between March 11
th, 2005
and December 31
st, 2009 were selected for the study arm.
Sodium acetate was mixed with sterile water to create a
chloride free solution. Initial resuscitation was started in
the trauma bay with normal saline. Those who remained
acidotic after initial crystalloid resuscitation in the
trauma bay or operating room and where large volumes
of resuscitation were anticipated were started on sodium
acetate. Patients were chosen at the discretion of the
attending surgical intensivist. Most patients were started
on sodium acetate within six hours of arrival. The rate of
infusion was chosen based on the patients weight and
anticipated fluid volume deficit.
The retrospective review of patient records was
approved by our hospital Institutional Review Board
(IRB) prior to commencement. Prospective individual
informed consent was not obtained as sodium acetate is
used routinely at our institution as well as neighboring
hospitals.
Patients were excluded based on the following exclu-
sion criteria: patients who were given sodium bicarbonate
within 48 hours of starting sodium acetate, those given
sodium acetate as a bolus, non-trauma patients, burn
patients, patients who expired within 24 hours of arrival
to the SICU, patients diagnosed with rhabdomyolysis and
patients whose medical record could not be obtained.
Demographic data was collected for each patient
including: age, sex, diagnosis, admission and discharge
dates, length of stay, reason for SICU admission, Injury
Severity Score (ISS) [7], outcome (expired or discharged)
and how the sodium acetate was administered. Total
acetate load was calculated from rate and duration of
infusion. Vital signs and laboratory values at six hours
and one hour prior to the initiation of sodium acetate
infusion as well as during the hour of infusion, one, six,
twelve, twenty-four, forty-eight and seventy-two hours
after initiation of infusion. For each time interval, the
patients systolic and diastolic blood pressure, mean
arterial pressure, arterial blood gas values including pH,
lactate and base excess were recorded. From chemistry
data the chloride and bicarbonate levels were also
recorded. Vital signs were obtained from nursing flow-
sheets which records values for each hour. Measure-
ments from arterial lines were used if available, and cuff
pressures when not. The chemistry and blood gas data
drawn closest to the time interval of interest was chosen
with predetermined cut off times.
A control arm was then created using patients
admitted between the years 2003 and 2004. During this
interval, sodium acetate was not being used and trauma
patients were resuscitated with normal saline. All
patients in our trauma registry with a matching ISS
score to a patient in the study arm were selected. Those
patients were then filtered based on the same exclusion
criteria outlined above. A single patient was chosen
with the best matching pH (+/- 0.03) and base deficit
(+/- 3) to the corresponding patient in the acetate
group. Time zero was assigned to simulate the start
time of the matched patient in the study group. Patients
were excluded if they did not have at least three blood
gas draws or had less than 36 hours of blood gas data.
T h es a m ef i e l d sw e r er e c o r d e df o rt h ec o n t r o la sw a s
for the sodium acetate arm.
A subset analysis was performed on patients who did
not receive vasopressors to eliminate its hemodynamic
influence on sodium acetate infusion.
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Data was analyzed using SPSS (SPSS Inc., Chicago, Il.).
Median values were used to limit outliers and minimize
variance. Regression values were plotted within SPSS.
Wilcoxon signed rank test was used due to the small
sample size, non-normal distribution of the study popu-
lation and repeated measurements performed.
Results
Initial selection yielded 89 patients for the sodium acet-
ate arm and 1107 patients for the control pool. After
evaluation for exclusion criteria and matching, there
were 39 patients eligible for the study group and a cor-
responding 39 patients were matched from the remain-
ing control pool. Six patients could not be matched for
ISS and the next closest ISS was used.
D e m o g r a p h i cd a t ai sp r e s e n t e di nT a b l e1 .A g ea n d
sex between study and control groups were not statisti-
cally significant. The mean ISS between the two groups
were 32.6 and 31.1 in the study and control groups
respectively. Vasopressors were used in 43.6% of the
study group and 30.7% of control group which was not
statistically different (p-value = 0.23). Mean infusion
time of sodium acetate was 38.1 hours. The estimated
acetate loads range from 5.02 to 182.1 total grams.
Figures 1, 2, 3, 4, 5, 6 plot median values for each para-
meter collected for both the study and control arms.
Mean arterial pressure (MAP) trended up in both the
study and control arms. The control arm had an initial
drop in MAP which improved with time. Regression line
comparison did not show a statistically significant differ-
ence between the two groups with a p-value of 0.257.
There were no clinically significant changes in MAP dur-
ing the time intervals studied. The median pH at time
zero was 7.32 and 7.31 in the sodium acetate and control
arms, respectively. There was normalization of the pH
over time in both groups. The study group showed a
more rapid improvement in pH but both groups normal-
ized by the end of the study period. When comparing
regression lines a p-value of 0.175 suggested no statistical
difference. The median serum bicarbonate level at time
zero was 19 mmol/L in the study arm and 20 mmol/L in
the control arm. The study arm patients began with
much lower bicarbonate levels prior to time zero. The
plots show a more rapid improvement of bicarbonate in
the study group as compared to the control. Comparison
of regression lines did not show a statistically significant
change between the two groups with a p-value of 0.93.
Patients in both groups were hyperchloremic prior to the
start of infusion. The median serum chloride concentra-
tion was 118 mEq/L in both the study and control arms
at time zero. Both trended toward normal over time. The
p-value was 0.618 when comparing regression lines.
Median lactate levels at time zero were 2.9 mmol/L in
the study group and 4.3 mmol/L in the control group. In
both groups lactate trended down. Regression lines were
not significantly different with a p-value of 0.792. Both
groups began with high base deficits which trended
toward normal during the study period. Regression lines
were not significantly different with a p-value of 0.498.
Within the sodium acetate group there were 17
patients who received vasopressors and 12 patients in
the control group. Vasopressors consisted almost exclu-
sively of norepinephrine, for those who did not respond,
vasopressin was also used. In order to limit vasopressor
influence, a subset-analysis was performed on those
patients who did not receive vasopressors comparing the
study arm and control arm. Each time interval was com-
pared to time zero using Wilcoxon signed rank test,
p-values are reported (Table 2). A statistically significant
rise in MAP values starting at 24 hours post start of
acetate infusion for the study group was found. For the
control group, there were no statistically significant
changes as compared to time zero for the duration of
Table 1 Demographic data
Sodium Acetate Control P-Value
N 39 39
Mean Age 43.4 (21-86) 39.9 (15-90) 0.24
Sex M/F (% Males) 28/11 (71.8%) 30/9 (76.9%) 0.53
Mean ISS Score 32.6 (4-75) 31.1 (14-50)
Patients on Vasopressors 17 (43.6%) 12 (30.7%) 0.23
Mean Infusion Time (hours) 38.1 (4-167)
Median Acetate Load (grams) 31.8 (5.02 - 182.1)
Type of Trauma
MVC 15 (38.5%) 27 (69.2%) 0.01
Auto vs peds/cycle 13 (33.3%) 5 (12.8%) 0.05
GSW/Stab 4 (10.3%) 7 (17.9%) 0.26
Other 7 (17.9%) 0 0.01
McCague et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011, 19:24
http://www.sjtrem.com/content/19/1/24
Page 3 of 6the study period. Neither group showed drops in hemo-
dynamic variables.
Discussion
In this study, we show that sodium acetate infusion in
the critically ill patient is a viable alternative in the
prevention of hyperchloremic metabolic acidosis. To
date, there have been no published studies evaluating
the use of sodium acetate in critically ill trauma
patients. Previously published studies have suggested
that sodium acetate can cause hemodynamic instability
in dialysis patients. We have used sodium acetate for
five years in our SICU without experiencing clinically
evident hemodynamic instability. This study looks at
the effects of sodium acetate on hemodynamic stability
and hyperchloremia.
Our study of the use of sodium acetate in trauma
patients did not reveal the hemodynamic instability as
seen in previous studies where sodium acetate is used in
dialysis patients. Sodium acetate improved acidosis fas-
ter, without drops in hemodynamic parameters. The use
of a chloride free solution prevents the accumulation of
Figure 1 Scatter plot of median mean arterial pressures, study
versus control arms. Start time (0 hours) and mean infusion time
(38 hours) noted with vertical lines. Regression lines plotted with p-
value 0.257.
Figure 2 Scatter plot of median pH, study versus control arms.
Start time (0 hours) and mean infusion time (38 hours) noted with
vertical lines. Regression lines plotted with p-value 0.175.
Figure 3 Scatter plot of median bicarbonate, study versus
control arms. Start time (0 hours) and mean infusion time (38
hours) noted with vertical lines. Regression lines plotted with p-
value 0.93.
Figure 4 Scatter plot of median chloride, study versus control
arms. Start time (0 hours) and mean infusion time (38 hours) noted
with vertical lines. Regression lines plotted with p-value 0.618.
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acidosis.
Though there are limitations to our study we feel that
the use of sodium acetate is a viable alternative to nor-
mal saline during resuscitation of trauma patients. The
small sample size in our study limits the clinical rele-
v a n c eo fo u rr e s u l t sa n dm a yl e a dt oah i g h e rr i s ko f
Type I statistical error. We are limited by the number of
available patients during this time period. There is also a
lack of standardization when choosing which patients
received sodium acetate. Though initially designed to
avoid a selection bias, from preferentially choosing
sicker patients to receive sodium acetate, use of histori-
cal cohorts from different time periods may actually
introduce selection bias as the resuscitation strategies
may have changed over time. Similarly, excluding
patients who expired within 24 hours may have elimi-
nated those patients who needed sodium acetate the
most. Being a retrospective study, measuring acetate and
sodium load for each patient is not possible, patients are
exposed to multiple sources of each. An exact measure-
ment will help control for this variation. The use of ISS
inherently has limitations, patients with similar ISS may
have very different injuries and different outcomes. The
use of vasopressors amongst a large portion of our
patients may reduce the clinical relevance of the results.
Vasopressors not only affect blood pressure, they can
also affect pH. However, a subset analysis was per-
formed with patients not on vasopressors showed no
adverse hemodynamic instability. Future work will
include a prospective randomized study which will help
to overcome the significant limitations of a retrospective
study. Currently we can only comment on trends within
the data and are not able to make absolute conclusions.
Our analysis of the use of sodium acetate during
resuscitation of trauma patients has shown that sodium
acetate is an alternative to normal saline and lactated
ringers in prevention of hyperchloremic metabolic
acidosis. Previous reports of hemodynamic instability
are not validated in this study.
Conclusion
We analyzed the use of sodium acetate in critically ill
trauma patients at a single center, during a four-year
period. Our data shows that the hemodynamic profile
remained favorable, without evidence of instability at
any point during the study period regardless of vaso-
pressor use. Normalization of hyperchloremia and meta-
bolic acidosis occurred faster in this group compared to
control patients.
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Figure 5 Scatter plot of median lactate, study versus control
arms. Start time (0 hours) and mean infusion time (38 hours) noted
with vertical lines. Regression lines plotted with p-value 0.792.
Figure 6 Scatter plot of median base deficit, study versus
control arms. Start time (0 hours) and mean infusion time (38
hours) noted with vertical lines. Regression lines plotted with
p-value 0.498.
Table 2 Comparison of MAP at time zero to each
subsequent interval for patients who did not receive
vasopressors
Time (Hours)
0t o1 0t o6 0t o1 2 0t o2 4 0t o4 8 0t o7 2
Acetate 0.896 0.183 0.408 0.011 0.017 0.004
Control 0.926 0.881 0.983 0.632 0.058 0.177
P-values listed (statistical significance defined by <0.05).
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